January 29th 2020
Ankit Kansagra, MD, discusses the evolving use of CAR T-cell therapy in multiple myeloma and lymphoma.
January 28th 2020
Prapti Patel, MD, discusses available and emerging treatment options for patients with acute myeloid leukemia.
January 24th 2020
Mira Hellmann, MD, discusses surgical and systemic advancements in the field of gynecologic oncology.
January 23rd 2020
Sandy W. Wong, MD, discusses treatments in the pipeline for multiple myeloma.
January 22nd 2020
Ruth O’Regan, MD, and Adam M. Brufsky, MD, PhD, FACP, both discuss the emergence of trastuzumab biosimilars in breast cancer.
January 15th 2020
Nancy U. Lin, MD, discusses research focusing on CNS penetration in HER2-positive metastatic breast cancer.
January 14th 2020
Erika P. Hamilton, MD, discusses research presented at the 2019 San Antonio Breast Cancer Symposium and how the data are impacting the treatment of patients with HER2-positive breast cancer.
Hope S. Rugo, MD, FASCO, discusses the updated findings of the SOPHIA trial in HER2-positive metastatic breast cancer.
Rashmi K. Murthy, MD, MBE, discusses the findings of the HER2CLIMB trial in heavily pretreated patients with unresectable locally advanced or metastatic HER2-positive breast cancer.
January 13th 2020
Martine J. Piccart, MD, PhD, discusses the 6-year follow-up of the APHINITY trial and its impact on the breast cancer field.
January 10th 2020
David F. McDermott, MD, discusses developments in the frontline setting for the treatment of patients with advanced renal cell carcinoma.
January 9th 2020
Alice Mims, MD, discusses biomarker research and therapeutic developments in acute myeloid leukemia.
January 8th 2020
Jennifer A. Woyach, MD, discusses the evolving treatment paradigm and sequencing challenges in chronic lymphocytic leukemia.
January 7th 2020
Maria Chaudhry, MBBS, discusses recent and ongoing research in newly diagnosed and relapsed/refractory multiple myeloma.
January 6th 2020
Ajjai Shivaram Alva, MBBS, highlights ongoing advances made in the treatment of patients with metastatic renal cell carcinoma.
Afonso Ribeiro, MD, discusses imaging modalities as well as challenges and future goals for the pancreatic cancer paradigm.
January 2nd 2020
Nathan Pennell, MD, PhD, discusses the emerging widespread role of liquid biopsies in lung cancer and how to best utilize the approach in clinical practice.
December 28th 2019
Melissa L. Larson, MD, discusses available treatments for patients with acute myeloid leukemia, as well as others that are in the pipeline.
December 23rd 2019
Julie R. Gralow, MD, discusses the emergence of biosimilars in the United States and globally.
December 20th 2019
Brian A. Van Tine, MD, PhD, discusses the results of a phase I study looking at the effects of ADP-A2M4 in patients with synovial sarcoma.